Download FREE Sample
Report Overview
Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop resilience, and creating environmentally friendly industrial processes. Innovations like gene editing, synthetic biology, and regenerative medicine continue to expand biotechnology-s applications, addressing global challenges in medicine, food security, and sustainable resource management.
To learn more about this report, download the PDF brochure
Advancements in genetic engineering and genomics to propel market demand
Advancements in genetic engineering and genomics are significantly propelling the biotechnology market by enabling precise modifications at the genetic level, fostering breakthroughs in personalized medicine, gene therapies, and biopharmaceuticals. Techniques like CRISPR-Cas9 and next-generation sequencing (NGS) have transformed disease treatment and prevention, allowing for targeted therapies that cater to individual genetic profiles. These innovations support the development of therapies for previously untreatable diseases and improve crop resilience in agriculture. Additionally, genomics-based data analytics facilitate faster drug discovery and development processes, reducing R&D costs and time-to-market. This precision and efficiency are attracting substantial investments across the biotechnology sector.
Growing demand for biopharmaceuticals is driving the market growth
The growing demand for biopharmaceuticals is a major driver of biotechnology market growth, as biologic drugs like monoclonal antibodies, vaccines, and cell therapies offer targeted treatments with fewer side effects compared to traditional medications. Biopharmaceuticals are particularly effective in treating complex chronic diseases, including cancer, autoimmune disorders, and genetic conditions. Their efficacy and specificity are fueling global demand, prompting biopharma companies to expand R&D investments. Additionally, advancements in biotechnology, such as recombinant DNA technology and advanced bio-manufacturing processes, enable efficient biopharmaceutical production, supporting rapid market expansion and the development of more personalized, high-impact therapies.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global biotechnology market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA; among others. Some of the key strategies adopted by market players include new product and service development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2025 |
| Historical Data | 2024 - 2025 |
| Forecast Period | 2026 - 2031 |
| Growth Rate | 14% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Technology, Application, Offering |
| Regional Scope |
|
| Key Companies Mapped | F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides the size of the global biotechnology market at the regional- and country-level from 2024 to 2031. The report further segments the market based on technology, application, and offering.
- Market Size & Forecast (2024-2031), By Technology, USD Million
- Nanobiotechnology
- Tissue Engineering and Regenerative Medicine
- DNA Sequencing and Genomics
- Cell-based Assays
- Fermentation Technology
- PCR Technology
- Chromatography
- CRISPR and Gene Editing
- Synthetic Biology
- Cell and Gene Therapy
- Bioinformatics
- Others
- Market Size & Forecast (2024-2031), By Application, USD Million
- Healthcare and Medical Biotechnology
- Agricultural Biotechnology
- Industrial Biotechnology
- Environmental Biotechnology
- Others
- Market Size & Forecast (2024-2031), By Offering, USD Million
- Biopharmaceuticals
- Bio-services
- Bio-agriculture Products
- Bio-industrial Products
- Diagnostic and Research Reagent
- Others
- Market Size & Forecast (2024-2031), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Frequently Asked Questions About This Report
What is the market size & forecast of the biotechnology market?
What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the biotechnology market?
What are the key trends defining the market?
What are the major factors impacting the market?
What are the opportunities prevailing in the market?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
